The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high ...

Genomics unveils Mystra at ASHG 2025—an AI genetics platform to accelerate drug discovery and clinical validation using large-scale genetic data.

About 30% of all respiratory tract infections are caused by coronaviruses, leading to widespread illnesses and, in some cases, to epidemic and even pandemic outbreaks, as we experienced with the COVID ...

U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda ...

In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim UF Scripps Institute has identified a potential new drug against the virus ...

SwRI developed a large language model called Generative Approaches for Molecular Encodings (GAMES) to generate Simplified Molecular Input Line Entry System (SMILES) strings, which offer a text-based ...

Generative models have gained widespread attention in recent years due to their inverse design capabilities and their potential to accelerate the molecular design and discovery processes. This ...

Dianthus Therapeutics and Boehringer Ingelheim headlined the latest round of licensing d | Dianthus and Boehringer Ingelheim ...

Drug discovery research is undergoing a rapid transformation driven by technological advances, including artificial intelligence (AI) and automation. Traditionally time-consuming and complex processes ...

Artificial intelligence (AI)-based drug developer Isomorphic Labs said it has raised $600 million in its first external funding round, with the proceeds expected to accelerate its research and ...

SHANGHAI & BOSTON--(BUSINESS WIRE)--Perpetual Medicines today announced it has closed an $8 million seed financing to advance its integrated computational design and synthesis platform for peptide ...